| scholarly article | Q13442814 |
| P356 | DOI | 10.1002/JPS.2600741208 |
| P698 | PubMed publication ID | 4087195 |
| P2093 | author name string | Chan KK | |
| Watson E | |||
| Dea P | |||
| P433 | issue | 12 | |
| P407 | language of work or name | English | Q1860 |
| P304 | page(s) | 1283-1292 | |
| P577 | publication date | 1985-12-01 | |
| P1433 | published in | Journal of Pharmaceutical Sciences | Q3186933 |
| P1476 | title | Kinetics of phosphoramide mustard hydrolysis in aqueous solution | |
| P478 | volume | 74 |
| Q58291979 | 31P NMR and HPLC Investigations of the Cyclophosphamide Metabolite, Phosphoramide Mustard |
| Q69428484 | Analysis of 4-hydroxycyclophosphamide by gas chromatography-mass spectrometry in plasma |
| Q69847347 | Analysis of clomesone in plasma by gas chromatography-electrolytic conductivity detection |
| Q71910959 | Analysis of ifosforamide mustard, the active metabolite of ifosfamide, in plasma |
| Q48331700 | Design and synthesis of a MAO-B-selectively activated prodrug based on MPTP: a mitochondria-targeting chemotherapeutic agent for treatment of human malignant gliomas |
| Q28829762 | Dexamethasone-(C21-phosphoramide)-[anti-EGFR]: molecular design, synthetic organic chemistry reactions, and antineoplastic cytotoxic potency against pulmonary adenocarcinoma (A549) |
| Q36311218 | Fludarabine- (C2-methylhydroxyphosphoramide)- [anti-IGF-1R]: Synthesis and Selectively "Targeted"Anti-Neoplastic Cytotoxicity against Pulmonary Adenocarcinoma (A549) |
| Q30652899 | Identification of new aqueous chemical degradation products of isophosphoramide mustard |
| Q33828848 | Involvement of a volatile metabolite during phosphoramide mustard-induced ovotoxicity |
| Q68680019 | Kinetics of hydrolysis in vitro of nornitrogen mustard, a metabolite of phosphoramide mustard and cyclophosphamide |
| Q46467130 | Preclinical pharmacokinetics and stability of isophosphoramide mustard |
Search more.